Nevus of Ota: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
[[File: | {{SI}} | ||
{{Infobox medical condition | |||
| name = Nevus of Ota | |||
| image = [[File:Naveus_of_ota.jpg|250px]] | |||
| caption = Nevus of Ota on the face | |||
| synonyms = Oculodermal melanocytosis | |||
| pronunciation = | |||
| specialty = [[Dermatology]] | |||
| symptoms = Blue or gray patch on the face, usually around the eye | |||
| onset = Congenital or early childhood | |||
| duration = Lifelong | |||
| causes = [[Melanocyte]] proliferation | |||
| risks = Increased risk of [[glaucoma]] | |||
| diagnosis = Clinical examination | |||
| differential = [[Nevus of Ito]], [[Mongolian spot]], [[Melanoma]] | |||
| treatment = [[Laser therapy]], [[cosmetic camouflage]] | |||
| frequency = More common in [[Asian]] populations | |||
}} | |||
'''Nevus of Ota''' is a dermal melanocytic hamartoma, which presents as a blue or grayish patch on the face, particularly around the eye area. It is a type of [[dermal melanocytosis]] and is more commonly observed in individuals of Asian descent, particularly Japanese and Chinese populations. The condition is named after the Japanese dermatologist [[Masao Ota]], who first described it in 1939. | '''Nevus of Ota''' is a dermal melanocytic hamartoma, which presents as a blue or grayish patch on the face, particularly around the eye area. It is a type of [[dermal melanocytosis]] and is more commonly observed in individuals of Asian descent, particularly Japanese and Chinese populations. The condition is named after the Japanese dermatologist [[Masao Ota]], who first described it in 1939. | ||
==Presentation== | ==Presentation== | ||
Nevus of Ota typically appears as a unilateral, bluish or grayish discoloration on the face. The pigmentation is due to the presence of melanocytes in the dermis. It most commonly affects the areas innervated by the first and second branches of the [[trigeminal nerve]], including the forehead, temple, periorbital region, and cheek. In some cases, the sclera and other parts of the eye may also be involved, leading to ocular complications. | Nevus of Ota typically appears as a unilateral, bluish or grayish discoloration on the face. The pigmentation is due to the presence of melanocytes in the dermis. It most commonly affects the areas innervated by the first and second branches of the [[trigeminal nerve]], including the forehead, temple, periorbital region, and cheek. In some cases, the sclera and other parts of the eye may also be involved, leading to ocular complications. | ||
==Pathophysiology== | ==Pathophysiology== | ||
The exact cause of Nevus of Ota is not well understood, but it is believed to result from the failure of neural crest cells to migrate properly during embryonic development. These cells remain in the dermis and produce melanin, leading to the characteristic pigmentation. The condition is usually congenital, but it can also appear during adolescence. | The exact cause of Nevus of Ota is not well understood, but it is believed to result from the failure of neural crest cells to migrate properly during embryonic development. These cells remain in the dermis and produce melanin, leading to the characteristic pigmentation. The condition is usually congenital, but it can also appear during adolescence. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Nevus of Ota is primarily clinical, based on the characteristic appearance of the lesion. [[Dermatoscopy]] can be used to examine the lesion more closely. In some cases, a biopsy may be performed to rule out other conditions, such as [[melanoma]]. | Diagnosis of Nevus of Ota is primarily clinical, based on the characteristic appearance of the lesion. [[Dermatoscopy]] can be used to examine the lesion more closely. In some cases, a biopsy may be performed to rule out other conditions, such as [[melanoma]]. | ||
==Treatment== | ==Treatment== | ||
While Nevus of Ota is a benign condition, treatment may be sought for cosmetic reasons. The most effective treatment is laser therapy, particularly with Q-switched lasers, which target the melanin in the dermis and help to lighten the pigmentation. Multiple sessions are often required for optimal results. | While Nevus of Ota is a benign condition, treatment may be sought for cosmetic reasons. The most effective treatment is laser therapy, particularly with Q-switched lasers, which target the melanin in the dermis and help to lighten the pigmentation. Multiple sessions are often required for optimal results. | ||
==Prognosis== | ==Prognosis== | ||
Nevus of Ota is a benign condition and does not typically pose any health risks. However, there is a small risk of malignant transformation into melanoma, particularly in the ocular region. Regular monitoring by a dermatologist or ophthalmologist is recommended. | Nevus of Ota is a benign condition and does not typically pose any health risks. However, there is a small risk of malignant transformation into melanoma, particularly in the ocular region. Regular monitoring by a dermatologist or ophthalmologist is recommended. | ||
==Also see== | ==Also see== | ||
* [[Nevus of Ito]] | * [[Nevus of Ito]] | ||
Latest revision as of 06:02, 8 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Nevus of Ota | |
|---|---|
| |
| Synonyms | Oculodermal melanocytosis |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Blue or gray patch on the face, usually around the eye |
| Complications | N/A |
| Onset | Congenital or early childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Melanocyte proliferation |
| Risks | Increased risk of glaucoma |
| Diagnosis | Clinical examination |
| Differential diagnosis | Nevus of Ito, Mongolian spot, Melanoma |
| Prevention | N/A |
| Treatment | Laser therapy, cosmetic camouflage |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | More common in Asian populations |
| Deaths | N/A |
Nevus of Ota is a dermal melanocytic hamartoma, which presents as a blue or grayish patch on the face, particularly around the eye area. It is a type of dermal melanocytosis and is more commonly observed in individuals of Asian descent, particularly Japanese and Chinese populations. The condition is named after the Japanese dermatologist Masao Ota, who first described it in 1939.
Presentation[edit]
Nevus of Ota typically appears as a unilateral, bluish or grayish discoloration on the face. The pigmentation is due to the presence of melanocytes in the dermis. It most commonly affects the areas innervated by the first and second branches of the trigeminal nerve, including the forehead, temple, periorbital region, and cheek. In some cases, the sclera and other parts of the eye may also be involved, leading to ocular complications.
Pathophysiology[edit]
The exact cause of Nevus of Ota is not well understood, but it is believed to result from the failure of neural crest cells to migrate properly during embryonic development. These cells remain in the dermis and produce melanin, leading to the characteristic pigmentation. The condition is usually congenital, but it can also appear during adolescence.
Diagnosis[edit]
Diagnosis of Nevus of Ota is primarily clinical, based on the characteristic appearance of the lesion. Dermatoscopy can be used to examine the lesion more closely. In some cases, a biopsy may be performed to rule out other conditions, such as melanoma.
Treatment[edit]
While Nevus of Ota is a benign condition, treatment may be sought for cosmetic reasons. The most effective treatment is laser therapy, particularly with Q-switched lasers, which target the melanin in the dermis and help to lighten the pigmentation. Multiple sessions are often required for optimal results.
Prognosis[edit]
Nevus of Ota is a benign condition and does not typically pose any health risks. However, there is a small risk of malignant transformation into melanoma, particularly in the ocular region. Regular monitoring by a dermatologist or ophthalmologist is recommended.
